Published in Cancer Weekly, July 19th, 2005
"Mortality from breast cancer has decreased in large part because of adjuvant chemotherapy. Sequelae of therapy include ovarian failure and bone loss - loss that would increase these patients' risk of fracture with aging," wrote G.E.H. Fuleihan and colleagues, American University of Beirut, who conducted a study of "the efficacy of pamidronate in preventing such loss."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.